Australian Gonococcal Surveillance Programme, 1 January to 31 March 2020

Commun Dis Intell (2018). 2020 Jul 15:44. doi: 10.33321/cdi.2020.44.61.

Authors

Monica M Lahra¹, Masoud Shoushtari¹, Tiffany R Hogan²

Affiliations

¹ The World Health Organisation Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, New South Wales Health Pathology, Microbiology The Prince of Wales Hospital, Randwick, NSW, 2031.
² The World Health Organisation Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, New South Wales Health Pathology, Microbiology.

PMID: 32664833
DOI: 10.33321/cdi.2020.44.61

No abstract available

© Commonwealth of Australia CC BY-NC-ND.

Publication types

Historical Article

MeSH terms

Anti-Bacterial Agents / pharmacology*
Australia / epidemiology
Azithromycin
Ceftriaxone
Drug Resistance, Bacterial
Gonorrhea / epidemiology*
Gonorrhea / history
Gonorrhea / microbiology
History, 21st Century
Humans
Microbial Sensitivity Tests
Neisseria gonorrhoeae / drug effects*
Public Health Surveillance*

Substances

Anti-Bacterial Agents
Ceftriaxone
Azithromycin